| Literature DB >> 25511081 |
Eva van het Reve1, Eling D de Bruin.
Abstract
BACKGROUND: Exercise interventions often do not combine physical and cognitive training. However, this combination is assumed to be more beneficial in improving walking and cognitive functioning compared to isolated cognitive or physical training.Entities:
Mesh:
Year: 2014 PMID: 25511081 PMCID: PMC4293005 DOI: 10.1186/1471-2318-14-134
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Figure 1The trained muscle groups of the strength training. (Ab HUR Oy, 67100 Kokkola, Finland, http://www.hur.fi).
Figure 2Exercise example from the cognitive exercise program: a participant training selective attention.
Participants’ demographic and baseline characteristics
| Group | ||
|---|---|---|
| No. of participants with a complete questionnaire | 76 | 69 |
| Age (mean ± SD) | 81.9 ± 6.3 | 81.1 ± 8.3 |
| Sex (female, male) | 52, 30 | 49, 25 |
| MMSE score (mean ± SD) | 27.7 ± 2.9 | 27.6 ± 2.6 |
|
| ||
| Slow walking speed (<1.22 m/s) n(%) | 64 out of 77(83) | 62 out of 74(84) |
| Fell in the last 6 months n(%) | 23(30) | 20(29) |
| 3 or more prescription medications n(%) | 45(59) | 51(73) |
| Physical functioning; SPPB (mean ± SD) | 7.3 ± 2.6 | 7.3 ± 2.6 |
| Fear of falling; FES-I (mean ± SD) | 25.4 ± 8.0 | 26.8 ± 9.6 |
|
| ||
| University/College | 4(5) | 7(10) |
| Vocational Education | 52(68) | 41(59) |
| No educated profession | 20(26) | 21(30) |
| In a sitting position past profession | 15(20) | 18(26) |
|
| ||
| Number of self-reported chronic diseases | ||
| Joint diseases | 35(46) | 34(49) |
| Hypertension | 40(53) | 37(54) |
| Cardiac Problems | 27(36) | 29(42) |
| Osteoporosis | 13(17) | 12(17) |
| Type II diabetes mellitus | 9(12) | 11(16) |
| Problems limiting walking function | ||
| Self-reported walking problems | 31(41) | 34(49) |
| Problems with legs | 40(53) | 41(59) |
| Need walking aid | 31(41) | 36(52) |
| Hearing problems | 41(54) | 35(51) |
| Vision problems | 34(45) | 32(46) |
| Dizziness | 28(37) | 21(30) |
| Estimated good health | 48(63) | 36(52) |
| Estimated better health compared with contemporary | 26(34) | 23(33) |
| Estimated good balance | 29(38) | 22(32) |
| Feel pain daily | 22(29) | 22(32) |
|
| ||
| Practiced some sport in the past | 34(45) | 34(49) |
| Practiced strength exercises in the past | 6(8) | 5(7) |
Figure 3The study flow chart.
Dual task costs of walking of and from pre- to post-test, between-groups differences and interaction effects
| pre-post differences (both groups) | between-groups differences | interaction effect | |||||
|---|---|---|---|---|---|---|---|
| Pre-test (mean ± SD) | Post-test (mean ± SD) | Pre-test (mean ± SD) | Post-test (mean ± SD) | pwithin/η2 | pbetween/η2 | pinteraction/η2 | |
|
| |||||||
| Velocity (%) | 13.9 ± 17.8 | 12.2 ± 15.0 | 17.5 ± 18.4 | 11.0 ± 17.5 | 0.002*/0.051 | 0.588/0.002 | 0.067°/0.019 |
| Step time (%) | 12.0 ± 25.2 | 9.6 ± 14.4 | 31.3 ± 88.7 | 10.0 ± 18.7 | 0.018*/0.033 | 0.061°/0.021 | 0.061°/0.021 |
| Step length (%) | 6.6 ± 9.0 | 6.6 ± 8.4 | 7.4 ± 9.7 | 4.4 ± 9.5 | 0.025*/0.028 | 0.558/0.002 | 0.028*/0.028 |
| SD step length (%) | 28.7 ± 53.2 | 27.9 ± 54.2 | 24.7 ± 50.4 | 18.0 ± 51.7 | 0.426/0.004 | 0.298/0.007 | 0.531/0.002 |
|
| |||||||
| Velocity (%) | 26.5 ± 13.2 | 21.9 ± 9.0 | 28.6 ± 13.3 | 22.7 ± 13.1 | <0.001*/0.126 | 0.355/0.005 | 0.545/0.002 |
| Step time (%) | 23.1 ± 24.5 | 17.2 ± 10.1 | 18.8 ± 12.7 | 17.5 ± 17.2 | 0.035*/0.028 | 0.368/0.005 | 0.177/0.012 |
| Step length (%) | 10.8 ± 8.5 | 10.3 ± 6.7 | 13.1 ± 8.5 | 9.8 ± 8.3 | 0.001*/0.073 | 0.426/0.004 | 0.009*/0.040 |
| SD step length (%) | 17.1 ± 34.9 | 50.3 ± 150.1 | 25.1 ± 54.7 | 20.1 ± 43.2 | 0.311/0.006 | 0.625/0.001 | 0.014*/0.036 |
Notes: * = significant within-groups differences pre-post (pwithin ≤ 0.05) & significant interactions of the groups (pinteraction ≤ 0.05); ° = trends to significant within-groups differences pre-post (0.05 ≥ pwithin ≤ 0.10), calculated with ANOVA. Abbreviations: DTC dual task costs, η2: effect size η2 = .01; small effect, η2 = .06; moderate effect, η2 = .14; large effect.
Pre- and post-test performance for and , differences between groups and interaction effects
| Pre-post differences (both groups) | Between-groups differences | Interaction effect | |||||
|---|---|---|---|---|---|---|---|
| Pre-test (mean ± SD) | Post-test (mean ± SD) | Pre-test (mean ± SD) | Post-test (mean ± SD) | ||||
|
| |||||||
| RT right hand | 362.7 ± 94.8 | 300.9 ± 57.3 | 383.0 ± 129.4 | 318.2 ± 69.0 | <0.001*/0.323 | 0.108/0.014 | 0.820/0 |
| RT left hand | 362.6 ± 88.8 | 298.4 ± 56.0 | 374.4 ± 109.6 | 318.2 ± 74.6 | <0.001*/0.339 | 0.145/0.012 | 0.524/0.002 |
| RT right foot | 423.5 ± 119.3 | 345.9 ± 67.2 | 472.5 ± 218.1 | 380.9 ± 101.1 | <0.001*/0.273 | 0.016*/0.032 | 0.500/0.003 |
| RT left foot | 410.1 ± 110.0 | 354.3 ± 83.4 | 442.2 ± 158.7 | 370.0 ± 82.8 | <0.001*/0.261 | 0.105/0.015 | 0.312/0.006 |
|
| |||||||
| FES-I | 25.4 ± 8.0 | 22.8 ± 7.0 | 26.8 ± 9.6 | 24.6 ± 8.5 | <0.001*/0.159 | 0.157/0.011 | 0.637/0.001 |
|
| |||||||
| TMT A | 83.4 ± 51.4 | 71.2 ± 47.3 | 81.5 ± 51.3 | 69.5 ± 43.4 | <0.001*/0.143 | 0.795/0 | 0.969/0 |
| TMT B | 188.5 ± 73.0 | 166.3 ± 75.0 | 189.5 ± 78.8 | 164.4 ± 76.9 | <0.001*/0.207 | 0.964/0 | 0.772/0.001 |
|
| |||||||
| RT upper channel | 940.1 ± 170.0 | 885.7 ± 169.9 | 1014.0 ± 209.7 | 907.4 ± 211.3 | <0.001*/0.217 | 0.066°/0.019 | 0.023*/0.028 |
| RT lower channel | 976.7 ± 181.5 | 893.1 ± 169.2 | 1012.3 ± 25.0 | 889.8 ± 204.9 | <0.001*/0.292 | 0.542/0.002 | 0.105/0.015 |
| MA upper channel | 10.7 ± 4.6 | 10.1 ± 5.0 | 13.3 ± 5.9 | 10.0 ± 5.5 | <0.001*/0.082 | 0.064°/0.019 | 0.001*/0.062 |
| MA lower channel | 13.5 ± 5.8 | 11.5 ± 5.7 | 15.0 ± 7.2 | 11.4 ± 6.2 | <0.001*/0.161 | 0.379/0.004 | 0.094°/0.015 |
Notes: *significant within-groups differences pre-post (pwithin ≤ 0.05), significant between-groups differences (pbetween ≤ 0.05) & significant interactions of the groups (pinteraction ≤ 0.05); °trends to significant within-groups differences pre-post (0.05 ≥ pwithin ≤ 0.10) & trends to significant interactions of the groups (0.05 ≥ pinteraction ≤ 0.10);, calculated with ANOVA. Abbreviations: η2 effect size η2 = .01, small effect, η2 = .06; moderate effect, η2 = .14; large effect, RT reaction time, FES-I Falls Efficacy Scale-International, MA missed answers.
Figure 4Falls per month for and . Legend: SB and SBC prior to study commencement (1; 6 months), during the study (2; 3 months), and after study completion (3; 12 months).